Statistical analysis of clinical data indicated that the expression levels of hCDC6 (human CDC6) in breast cancer (BRCA) and liver cancer (LIHC) were significantly higher than those in corresponding normal tissues (Figure 5A). The gene discussed is CDC6; the disease is liver cancer.